ITUS to Ring June 3, 2016 Nasdaq Closing Bell and Launch New Cancer Social Media Campaign

LOS ANGELES, CA -- (Marketwired) -- 05/31/16 -- ITUS Corporation (NASDAQ: ITUS) today announced that to commemorate National Cancer Survivor's Day on June 5, company representatives will ring the June 3, 2016 closing bell of The Nasdaq Stock Market. The occasion will also mark the official launch of a new cancer social media campaign entitled "Let's Get Crack'n Against Cancer."

To honor people affected by cancer, and bring additional focus and a renewed sense of urgency to the ongoing cancer healthcare crisis, the "Let's Get Crack'n Against Cancer" campaign will ask the public to post videos to Twitter, Facebook, and Instagram, indicating why Cancer Counts™ to them, and cracking eggs marked with the word "cancer."

Robert Berman, the president and CEO of ITUS and co-founder of Cancer Counts™ stated, "Cancer has devastated us for so long that it is most often associated with feelings of fear, trepidation, and apathy. However, changes in how we approach cancer are on the way that have the potential to significantly improve patient outcomes and that will finally give us the upper hand. We need to begin to change the perceptions about cancer and engage in a national cancer dialogue so that innovations happen faster, and people are prepared to embrace these changes."

The company's first Cancer Counts™ effort, called, launched three months ago with the purpose of making cancer a priority for our next president. With over 10,000 Cancer Counts "votes" registered on the C4P website, and thousands of emails sent to the presidential campaigns, C4P has been successful in getting one of presumptive party nominees to agree to formulate and present a policy for addressing the ongoing national cancer epidemic. The "Let's Get Crack'n" campaign will continue the effort to make cancer a part of the political agenda in the general election. Additional information about "Get Crack'n" is available at and on social media at #CancerCounts.

ITUS Corporation

ITUS funds, develops, acquires, and licenses emerging technologies in areas such as Biotechnology. The Company is developing Cchek™ a platform for non-invasive, cancer screening blood tests. Additional information is available at

Forward-Looking Statements: Statements that are not historical fact may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical facts, but rather reflect ITUS Corporation's current expectations concerning future events and results. We generally use the words "believes," "expects," "intends," "plans," "anticipates," "likely," "will" and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning our expectations, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in "Item 1A - Risk Factors" and other sections of our Annual Report on Form 10-K for the fiscal year ended October 31, 2015 as well as in our Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. You are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this press release.


Dean Krouch

Source: ITUS Corporation